Last updated 2026-06-18
- Acquired by Meridian Bioscience, May 2020
- Raised funding round, Nov 2010
Total raised
$10.7M
Last: 2010-11
Stage
Acquired
Founded
2006
Headcount
28
HQ
Modi'in-Maccabim-Re'ut, Israel
Sector
Health Tech & Life Sciences
About
Exalenz Bioscience develops and commercializes systems that extract vital information for diagnostics from subtle changes in patients' exhaled breath using the company's BreathID technology platform. The company's proprietary core technology enables medical specialists to easily identify and manage specific digestive and liver conditions while ensuring both clinical precision and patient comfort. The BreathID Hp is a clinically proven, easy, and accurate single-step urea breath test for diagnosing and monitoring H. pylori infection in adults.
Funding history · 1 round · $10.7M total
2010-11
Undisclosed
Q&A
- What is Exalenz Bioscience's primary business?
- Exalenz Bioscience develops and commercializes systems that extract vital information for diagnostics from subtle changes in patients' exhaled breath using its BreathID technology platform. The company's BreathID Hp is a single-step urea breath test for diagnosing and monitoring H. pylori infection in adults.
- When was Exalenz Bioscience founded?
- Exalenz Bioscience was founded in April 2006.
- What is the current status of Exalenz Bioscience?
- Exalenz Bioscience was acquired by Meridian Bioscience in May 2020 and is currently inactive.
- How many employees does Exalenz Bioscience have?
- Exalenz Bioscience has 11-50 employees.
- What is the total amount of funding Exalenz Bioscience has raised?
- Exalenz Bioscience has raised a total of $10,682,000 USD.
- Which investor participated in Exalenz Bioscience's funding round in November 2010?
- Accelmed participated in Exalenz Bioscience's funding round in November 2010.
- Where is Exalenz Bioscience's headquarters located?
- Exalenz Bioscience's headquarters is located in Modi'in-Maccabim-Re'ut, Center District, Israel.
- Who is the CEO of Exalenz Bioscience?
- Raffi Werner is the CEO of Exalenz Bioscience.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics DevicesMedical Monitors
Target customers
Healthcare & Life SciencesHealthcareProvidersLaboratories
Business model
B2B
Highlights
1 Patents
Tags
bioconvergencegastroenterologydiagnosticsreal-timebacteriaulcersmedical-technologiesnon-invasivelaboratoriesdoctorsclinicshealthcare-providers
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| linkedin.com/company/204415 | |
| facebook.com/Breathid | |
| YouTube | youtube.com/channel/UCScxGUH5Ii4stSAvmyCN9hQ |
| Wikipedia | en.wikipedia.org/wiki/Exalenz_Bioscience |
| Wikidata | wikidata.org/wiki/Q16975473 |
Identifiers & details
| Founded | 2006-4 |
|---|---|
| Employees (exact) | 28 |
| Offices | Manasquan |
| Status reason | Acquired (Inactive) by Meridian Bioscience on May 2020 - closed due to acquisition |
| Wikidata QID | Q16975473 |
Acquisitions & public offerings
Acquired by Meridian Bioscience 2020-05
Radar intelligence
Patents
| EPO | 11 |
|---|
Wikidata
| QID | Q16975473 |
|---|